Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Retirement is now part of the affordability crisis....
Business & Finance

Retirement is now part of the affordability crisis. Politicians should pay attention.

Retirement is now part of the affordability crisis. Politicians should pay attention.
MarketWatch Monday 09 November 2026, 13:30 UTC By David Conti 1 min read
Key Points

Americans are more concerned about retirement than ever, and some of their biggest fears can’t be fixed by individual behavior alone.

Americans are more concerned about retirement than ever, and some of their biggest fears can’t be fixed by individual behavior alone.
Americans (ORG)
Originally published by MarketWatch Read original →

Related Stories

Rising cost of living tests UK's net zero ambitions

From floods to wildfires to heatwaves, 2026 is the year it became hard to ignore the impact of climate change on UK weather. But will soaring living costs affect the government’s commitment to tackling climate change?

BBC Business 10m ago

Devils to sit star goalie vs his former team over 'win probability,' leaving NHL fans bewildered

The New Jersey Devils emerged as one of the best teams in the NHL this season and beefed up their roster when they acquired goaltender Connor Hellebuyck from the Winnipeg Jets. The Devils shut out the Toronto Maple Leafs on Sunday, increasing the anticipation for a matchup on Tuesday between New Jersey and Winnipeg in Canada. However, general manager Sunny Mehta shut down the possibility of Hellebuyck playing and gave a bizarre reason as to why.

Fox News 21m ago

How Indispensable Is Jensen Huang?

Jensen Huang, the C.E.O. of Nvidia, in March.

NYT Business 23m ago

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Supplements could be the next major sector to benefit from the weight-loss drug boom, Novonesis CEO told CNBC on Monday, as the biosolutions company explores whether microbiome products can help patients on popular GLP-1 medicines. "We have scientific evidence that [is] going to support the patients [on] GLP-1s feeling better, as a companion during the treatment," CEO Ester Baiget told "Squawk Box Europe," referencing an ongoing study with Novo Nordisk. GLP-1 medications and dietary...

CNBC 24m ago